Citius Oncology
Citius Oncology is a biopharmaceutical company that develops and commercializes oncology therapies. The company specializes in targeted therapies for cancer treatment, with a focus on immune-based approaches. The company recently gained FDA approval for LYMPHIR™, a therapy for relapsed or refractory cutaneous T-cell lymphoma.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Citius Oncology use?+
We have not yet detected technologies for Citius Oncology.
What industry is Citius Oncology in?+
Citius Oncology operates in the Medical industry.
Where is Citius Oncology based?+
Citius Oncology is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026